Company ProfilePremium

Personalized Nursing Services Societe Anonyme

Company Profile Analysis

Ticker: PNSB.BR

ESOMAR 23 Corporate BadgeISO Certifications Badge
Personalized Nursing Services Societe Anonyme - Company showcase

Year Founded & Workforce

2003

32 Employees

Personalized Nursing Services Societe Anonyme logo

Personalized Nursing Services Societe Anonyme Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Personalized Nursing Services Societe Anonyme Overview

UCare Services Belgique (formerly Personalized Nursing Services) is a founder-led micro-cap home-healthcare provider operating in French-speaking Belgium, principally the Mons-Borinage area of Hainaut, with historical activity in Brussels and Wallonia more broadly. It delivers nurse-led care at patients' homes (general nursing, palliative care, hygiene care, blood and urine sampling, peritoneal dialysis, stoma therapy, hospitalisation-at-home), provides nursing teams inside residential centres for people with disabilities and other institutions, and sells or rents medical equipment such as beds, incontinence products and pressure-sore prevention material. Revenue is overwhelmingly reimbursed care-act income tied to the Belgian INAMI/RIZIV nomenclature, plus institutional service contracts. Revenue peaked near €4.3M around 2009, stabilised at €2.5-3.0M during 2019-2023, then fell 34% to €1.75M in FY2024 with a €0.68M net loss. The shares, once the only listed company in Mons-Borinage, now trade nominally, with the instrument flagged inactive.


What the company does

UCare Services Belgique is a provider of nursing care services outside the hospital. Its activity has historically been organised around three pillars, as summarised consistently by MarketScreener, Zonebourse and Boursorama:

  1. Home medical assistance services — nursing acts at the patient's home, notably palliative care, blood sampling, peritoneal dialysis and stoma therapy (and, historically, physiotherapy/kinesitherapy).

  2. Care services in residential centres — the provision of nursing teams to institutions housing people with disabilities and other residential care facilities.

  3. Equipment leasing and sales — incontinence protection, medical beds, pressure-sore (escarre) prevention material and related supplies.

A more recent description (FinancialFilings) presents the offer as four branded divisions: "Ucare at Home" (home care), "Ucare Inside" (services inside hospitals and residential centres), "Ucare City" (health-centre operations) and "Ucare Furnitures" (sale and rental of medical equipment), with a 24/7 service model across French-speaking Belgium since 2003. Investing.com's profile extends the service list to general nursing, personal hygiene care, blood and urine analysis, physiotherapy and rehabilitation, peritoneal dialysis, haemodialysis, stoma therapy and hospitalisation at home.

The company's own description

On its investor page, CEO and managing director Nicola d'Aniello describes a company that has "always been in motion"; he credits the 2014 integration into the UCare Services franchise network with renewing the business while preserving the founding-nurse vision, says the company built a broad range of services over fifteen years for growing demand both at home and in institutions, and states that a mobile application rolled out in 2019 would make UCare a major actor of the "home healthcare revolution," with a return to profitable, sustainable growth targeted from 2019 (company website, undated message, c.2019). The website's operational counters claim 365-day operation, 5,000+ satisfied patients, 750+ care acts per day, 99 staff members and 25+ transports per day (company website, undated; likely c.2019-2020 vintage).

Business and revenue model

Revenue streamNaturePayerIndicative weightSource / basis
Home nursing actsFee-per-act / per-day forfaits under the Belgian INAMI/RIZIV nomenclature for nursing careMutualités (sickness funds) via third-party payer system; patient co-paymentDominant (76% of revenue in 2008 from nursing; 84% nursing vs 16% physiotherapy in 2011)L'Echo 25 Apr 2009; PNS press release 30 Mar 2012
Institutional nursingContracted nursing teams for residential centres / institutesInstitutions (often publicly funded)Material; three residential contracts terminated in Q4 2011; Ciney contract ramp-up from Oct 2011FY2011 annual report; press release 30 Mar 2012
Physiotherapy (CML subsidiary)Kinesitherapy actsSickness funds / patients16% of 2011 revenue (€0.583M); restructured 2010-2012; current status n/dPress release 30 Mar 2012
Equipment sales and rentalProduct resale and rentalPatients, institutionsMinor ("third pillar," L'Echo 2009)L'Echo 7 Jul 2009
Health-centre operations ("Ucare City")Primary-care centreSickness funds / patients—FinancialFilings

Independent characterisation: the model is service-based, labour-intensive and reimbursement-dependent, with no subscription or licensing component. Gross margin is driven by the spread between nomenclature fees and nurse labour cost (employees, interim agency staff and independent nurses). Management repeatedly identified nurse recruitment as the binding constraint on growth (FY2011 CEO commentary) and automatic wage indexation as the main margin risk (L'Echo, 25 Apr 2009 and 14 Oct 2008).

Value-chain position, customers and end-markets

The company sits at the point of care: it is the last link between prescribing physicians (general practitioners and hospital specialists), hospitals discharging patients, and the patient's home or institution. Customer types are (i) individual patients (often elderly, chronically ill, palliative or post-discharge), (ii) prescribing doctors and hospitals as referral sources, and (iii) residential institutions purchasing nursing capacity. End-markets: Belgian home nursing, institutional nursing for disabled persons, and home medical equipment. The geographic market is French-speaking Belgium, chiefly Hainaut (Mons, Borinage, La Louvière) and historically Walloon Brabant (Waterloo) and Namur province (Ciney).

Strategy

Stated strategy (themes from company communications)

The only articulated strategic statement is the CEO message on the investor page (c.2019), whose themes are: (i) continuous renewal through the UCare Services franchise network (joined 2014); (ii) a broad service range spanning home and institutional care; (iii) digital patient connectivity via a mobile app rolled out in 2019, positioning UCare in the "home healthcare revolution"; and (iv) a return to profitable and sustainable growth from 2019, supported by loyal shareholders. Earlier, management emphasised profitability preservation as the main objective (FY2011 report), recruitment of nursing staff via interim agencies, and new institutional collaborations.

Initiatives announced in the last 24 months (Oct 2024 – Oct 2026)

InitiativeDateDetailStatus
None verified—No company press releases, investor-day material or strategy updates have been published in this window. The only disclosure is the FY2024 results data point (Aug 2025).—
Rede D'Or partnership, BNDES funding round, "UCare AI" launchClaimed mid/Q3/Oct 2025Reported only by roic.ai; uncorroborated and inconsistent with company scale and geography—

Historical strategic initiatives (for context)

InitiativeDateDetailSource
Equipment sales as third pillarJul 2009Develop sale of medical material alongside nursing and physiotherapyL'Echo 7 Jul 2009
CML restructuring2010-2012Turnaround of physiotherapy subsidiary; relocation to La Louvière; target breakeven 2012-2013Press release 30 Mar 2012
Initialis site, Mons2,012Establish PNS on Mons science parkPress release 30 Mar 2012
Ciney institutional ramp-up2011-2012Scale from 24 to target 230 patientsPress release 30 Mar 2012
UCare franchise integration2,014Rebranding and network membershipCompany website
Name change to UCare Services BelgiqueDec 2018Corporate rebrandCompany website
Mobile app2,019Patient appCompany website

ESG commitments, cost programmes, medium-term targets

No ESG commitments, cost programmes with quantified targets, or medium-term financial guidance have been published since the 2008-2012 period (when the company issued revenue/profit forecasts and mentioned a possible revision of 2012-2014 objectives).

Products & Services

Flagship offerings: home nursing (the historical core, ≈76-84% of revenue when last disclosed) and institutional nursing. No product versions, technical specifications or list prices are published.

Product Portfolio

Segment / brandService or productDescription and capabilitiesTarget customerLaunch / latest yearPricing modelSource

Ucare at Home

General nursing care

Injections, dressings, wound care, medication support

Home patients on prescription

Since 2003

INAMI/RIZIV nomenclature fee per act

Euronext IPO summary; Investing.com

Ucare at Home

Personal hygiene care ("toilettes")

Daily hygiene care for dependent patients

Elderly / dependent patients

Since 2003

Nomenclature forfait

Euronext IPO summary

Ucare at Home

Palliative care

End-of-life nursing at home

Palliative patients and families

Pre-2006

Palliative nursing forfaits

Euronext IPO summary; MarketScreener

Ucare at Home

Blood sampling and urine analysis

Home sample collection

Patients prescribed lab tests

Pre-2006

Per act

Euronext IPO summary; Investing.com

Ucare at Home

Peritoneal dialysis

Home-based dialysis support

Renal patients

Pre-2006

Per act / forfait

Euronext IPO summary

Ucare at Home

Haemodialysis support

Listed by Investing.com

Renal patients

——

Investing.com

Ucare at Home

Stoma therapy

Ostomy care and education

Ostomy patients

Pre-2006

Per act

Euronext IPO summary

Ucare at Home

Hospitalisation at home

Post-acute care at home reducing length of stay

Hospital-discharged patients

——

Investing.com; FinancialFilings

Ucare at Home / CML

Physiotherapy and rehabilitation

Kinesitherapy at home and in centres (CML subsidiary)

Rehab patients

c.2008; restructured 2010-2012

Nomenclature

Press release 30 Mar 2012

Ucare Inside

Integrated care for disabled persons

Nursing teams in residential communities / institutes

Residential centres for handicapped people

Pre-2006

Contract

Euronext IPO summary; FY2011 report

Ucare City

Health centre

Primary-care centre operations

Local population

——

FinancialFilings

Ucare Furnitures

Medical beds

Sale and rental

Home patients

Pillar developed 2009

Sale / rental fee

L'Echo 7 Jul 2009; MarketScreener

Ucare Furnitures

Incontinence protection

Product resale

Home patients, institutions

2009

Retail price

MarketScreener

Ucare Furnitures

Pressure-sore prevention material

Mattresses / cushions etc.

Bedridden patients

2009

Sale / rental

MarketScreener

Digital

UCare Services Belgique mobile app

Patient connectivity app

Patients

Announced for 2019

—

Company website

Logistics

Patient transport / supply delivery

"25+ transports per day"

Patients

——

Company website

Financial Narrative

Important disclosure limitations. As a Marché Libre / Euronext Access issuer, the company is not required to publish IFRS financial statements, half-year reports or regulated information. The only verified five-year data are revenue (FY2019-FY2024) and net income (FY2023-FY2024) from S&P Capital IQ via MarketScreener. All other line items are not publicly disclosed in sources reviewed and are left blank.

Income statement: notes and sources

Sources: revenue FY2020-FY2023 MarketScreener/S&P Capital IQ; FY2024 revenue and FY2023-FY2024 net income from S&P Capital IQ results note (24 Aug 2025: sales €1.75M vs €2.66M; net loss €0.680738M vs €0.013585M). EPS calculated on 612,500 shares (no dilution disclosed). Dividends: last declared dividend was €0.10 for FY2016; no subsequent dividend notices found, so FY2023-FY2024 shown as 0 (inferred from absence of any coupon notice after coupon no. 10).

Long-run revenue history (context)

FY2008: guidance was €4.32M and actual revenue beat plan by 3% (L'Echo 12 Apr 2008 and 25 Apr 2009) — but the plan baseline is ambiguous, so the actual is left blank. FY2009 is implied from FY2010's -6.7% decline (calculated, approximate). FY2012-FY2018: n/d (only H1 2015 revenue of €2.381M, +7.3%, and pre-tax operating result of €0.258M are disclosed, per press release 11 Jan 2016).

Balance sheet

All n/d. Note: the FY2011 statutory accounts (Belgian GAAP) showed small items such as €5,000 of cash guarantees, €1,789.84 of inventories and €4,015.81 of capital subsidies, illustrating the very small balance sheet scale (FY2011 annual report).

Cash flow

Cash flow statements n/d. No buyback programme has ever been disclosed.

Ratios

All n/d: balance sheet and cash flow data unavailable: ### Commentary on trends, inflections and drivers

Phase 1 — growth to a 2008-2009 peak. Following the 2006 listing, PNS guided to strong growth, targeting €4.32M of revenue and €0.34M of net profit in 2008 (L'Echo, 12 April 2008). Revenue reached an implied ≈€4.28M in 2009. Profitability was then already sensitive to Belgian automatic wage indexation, which squeezed 2008 profits despite revenue beating plan (L'Echo, 25 April 2009).

Phase 2 — contraction and restructuring (2010-2012). Revenue fell 6.7% in 2010 to €3.99M (though profit rose) and a further 7.3% in 2011 to €3.699M. The physiotherapy subsidiary CML was the main drag, with revenue down 10.8% and a €0.122M restructuring charge; nursing also declined for the first time (-6.6%), hit by the termination of three residential contracts in Q4 2011. Management pinned recovery on the ramp-up of the Ciney institutional contract and on recruiting nurses through interim agencies (press release 30 March 2012).

Phase 3 — smaller but profitable (2013-2016). By H1 2015 the business was much smaller (€2.381M for the half — implying roughly €4.5-4.8M annualised only if seasonality is flat, which is inconsistent with later full-year figures; the H1 figure may include items such as gross "business volume" rather than revenue, so annualisation is not recommended) but profitable, with a pre-tax operating result of €0.258M and consecutive dividends of €0.10 (FY2013), €0.20 (FY2015) and €0.10 (FY2016). The 2014 move into the UCare franchise network coincided with this period.

Phase 4 — stagnation (2019-2023). Revenue oscillated in a narrow €2.53-2.97M band, peaking in FY2021 (€2.97M, likely helped by COVID-era home-care demand) before declining modestly in FY2022-FY2023. FY2023 was close to breakeven (net loss of €13.6K).

Phase 5 — sharp deterioration (FY2024). Revenue fell 34.2% to €1.75M and the net loss widened fifty-fold to €0.681M (net margin -38.9%). The FY2024 loss alone equals roughly 2.8× the company's market value at the last traded price. The reasons are not disclosed; plausible drivers (not confirmed by the company) include loss of one or more institutional contracts, nurse shortages limiting capacity, and the fixed-cost burden of a listed structure on a shrinking revenue base. The cumulative effect on equity cannot be assessed without the NBB-filed balance sheet, but a loss of this magnitude relative to the business's scale raises the question of whether Belgian Companies and Associations Code "alarm bell" provisions (net assets below half or a quarter of capital) may have become relevant — this is flagged as an analytical question, not a confirmed fact.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Revenue by Segment and Segment Margins & Growth (%)

MetricFY2019FY2020FY2021FY2022FY2023FY2024

Healthcare Facilities & Services revenue (EUR Mn)

2.532.822.972.722.661.75

YoY growth (%)

—11.55.3-8.4-2.2-34.2

Share of total revenue (%)

100100100100100100

Revenue by Segment and Revenue by Segment (%)

MetricFY2010FY2011

Group revenue (EUR Mn)

3.993.699

Nursing (PNS) revenue share (%)

8484

Physiotherapy (CML) revenue (EUR Mn)

0.6530.583

Physiotherapy (CML) revenue share (%)

1616

Nursing revenue YoY (%)

—-6.6

Physiotherapy revenue YoY (%)

—-10.8

Division (Brand) Overview

Division (brand)ContentRevenueSource

Ucare at Home

Home nursing: general care, palliative, hygiene, sampling, dialysis, stoma therapy, hospitalisation at home

—

FinancialFilings; company site

Ucare Inside

Nursing teams within hospitals and residential centres

—

FinancialFilings

Ucare City

Health-centre operations

—

FinancialFilings

Ucare Furnitures

Sale and rental of medical equipment

—

FinancialFilings; company site ("Vente et location de matériel")

Ucare Job

Recruitment portal for nurses

Not a revenue line

Company site

Income Statement and Margin Analysis (%)

MetricFY2020FY2021FY2022FY2023FY2024

Revenue (EUR Mn)

2.822.972.722.661.75

Revenue YoY growth (%)

11.55.3-8.4-2.2-34.2

Net income (EUR Mn)

———-0.014-0.681

EPS basic (EUR)

———-0.022-1.111

EPS diluted (EUR)

———-0.022-1.111

Dividend per share (EUR)

———00

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Margin Analysis (%)

MetricFY2020FY2021FY2023FY2024

Net margin (%)

——-0.5-38.9

CAGR measure

Value

Basis

——

Revenue CAGR FY2019-FY2023 (4 yrs)

+1.3%

€2.53M → €2.66M

——

Revenue CAGR FY2020-FY2024 (4 yrs)

-11.2%

€2.82M → €1.75M

——

Revenue change from c.2009 peak to FY2024

≈ -59%

≈€4.28M (implied from FY2010 €3.99M at -6.7%) → €1.75M

——

Income Statement

MetricFY2009FY2010FY2011FY2019FY2020FY2021FY2022FY2023FY2024

Revenue (EUR Mn)

4.283.993.6992.532.822.972.722.661.75

Financial Analysis

MetricFY2023FY2024

Dividends paid (EUR Mn)

00

Share buybacks (EUR Mn)

00

Revenue by Region and Region Margins & Growth (%)

RegionFY2019FY2020FY2021FY2022FY2023FY2024

Belgium revenue (EUR Mn)

2.532.822.972.722.661.75

Belgium YoY growth (%)

—11.55.3-8.4-2.2-34.2

Rest of world revenue (EUR Mn)

000000

Valuation Snapshot

MetricValueSource

Last price

€0.40

Yahoo Finance; TradingView; Boursorama

Date of last price change

11 Aug 2023 (all-time low)

TradingView

All-time high

€4.95 (2 Nov 2015)

TradingView

Decline from all-time high

-91.9%

Calculated

1-year performance (to Oct 2026)

0% (no trading)

Calculated

3-year performance

≈0% (price unchanged since Aug 2023)

Calculated

5-year performance

n/d (Oct 2021 price n/d)

—

Shares outstanding

612,500

Boursorama

Market capitalization

€0.245M

Calculated

Trading status

Inactive instrument

MarketScreener; FMP

Share Price

Metric201120152023

Reference share price (EUR)

2.504.950.40

Valuation Multiples

MultipleUCare (at €0.40, FY2024)Note

P/E

Not meaningful (loss)

EPS FY2024 -€1.11

P/Sales

0.14x

€0.245M / €1.75M

Per-Share Data

MetricFY2013FY2015FY2016

Gross dividend per share (EUR)

0.100.200.10

Coupon Details

CouponFiscal yearGross DPSApprovalPayment

No. 7

FY2013

€0.10

AGM 27 Jun 2014

Nov 2014 (ex 24 Nov 2014)

No. 8

Presumably FY2014

———

No. 9

FY2015

€0.20

AGM 25 Jul 2016

Dec 2016 (ex 19 Dec 2016)

No. 10

FY2016

€0.10

AGM 9 Nov 2017

2,018

FY2007

FY2007

Nil

——

Capital Markets

ItemStatus

Buyback authorisation

None disclosed

Moody's / S&P / Fitch ratings

Not rated

Bonds outstanding

None disclosed

Analyst Conclusions

Management guidance and consensus

No guidance has been issued since the 2008-2012 forecasts and the CEO's c.2019 aspiration to return to profitable growth. There is no consensus estimate.

Bull case

  1. Structural demand tailwind: ageing, chronic disease and shorter hospital stays expand demand for exactly the technical home-care acts (palliative, dialysis, stoma, hospitalisation at home) in which the company has two decades of experience.

  2. Demonstrated ability to operate near breakeven: FY2023 produced a loss of only €13.6K on €2.66M of revenue, showing the cost base can be roughly matched to a €2.5-3.0M revenue run-rate if volumes recover.

  3. Option value at a trivial valuation: at 0.14x FY2024 sales and €0.245M market value, any recovery of lost contracts, an asset sale of the patient base to a larger network, or a buy-out by the founder could crystallise value well above the last price.

Bear case

  1. Revenue collapse and heavy losses: a 34% revenue fall and a €0.681M loss in FY2024 suggest the business lost critical volume; at this scale, recovery requires capital and nurses that the company may not have.

  2. Governance and transparency deficit: a founder holding every senior role, no published annual reports, no AGM notices since 2022 and no FY2025 data leave minority shareholders with little visibility or protection.

  3. Untradeable equity: the instrument has been inactive since August 2023; even if fundamental value exists, minority holders may have no exit, and delisting or corporate restructuring could leave them with little.

Catalysts and monitorables (next 12 months)

MonitorableWhy it matters
Filing of FY2025 statutory accounts with the NBBReveals equity position, debt, liquidity and whether losses continued
AGM convening notice and agendaPossible alarm-bell procedure, capital measures, or delisting resolutions
Euronext notices on PNSBSuspension, delisting or reactivation of trading
Belgian Official Gazette (Moniteur belge) publicationsChanges to board, registered office, name, or any judicial reorganisation
Contract wins or losses with institutionsMain driver of revenue swings historically
Nurse staffing levelsCapacity constraint on revenue

Concluding analyst verdict

UCare Services Belgique — the former Personalized Nursing Services — is best understood not as an investable growth story but as a small, founder-run Walloon home-nursing business that happens to retain a dormant stock-market quotation. Its strategic logic is sound in principle: Belgium's ageing population, the policy push toward ambulatory and home-based care, and chronic nurse shortages all make reliable home and institutional nursing valuable. The company also has genuine operating heritage, with technical competencies in palliative care, dialysis and stoma therapy and a track record of paying dividends as recently as FY2016.

The evidence of the last five years, however, is discouraging. Revenue stagnated around €2.5-3.0M from 2019 to 2023 and then fell by a third in FY2024 to €1.75M, producing a net loss of €0.68M — a margin of roughly -39% and a figure close to three times the company's entire market value at the last traded price. Management has offered no public explanation, no recovery plan and no guidance. Governance is concentrated in a single individual, investor communication has effectively stopped since the December 2022 AGM notice, and the shares have not traded since August 2023, with the instrument now flagged inactive by data vendors.

For institutional investors, the security is effectively uninvestable: it lacks liquidity, disclosure, coverage and any verifiable balance-sheet information. For existing minority holders, the key question is solvency and the treatment of minorities in any restructuring, sale or delisting — matters that can only be assessed once the FY2024 and FY2025 statutory accounts are retrieved from the National Bank of Belgium. Investors should also explicitly disregard uncorroborated aggregator claims of Brazilian partnerships, BNDES funding or AI product launches. Verdict: Not rated / avoid; monitor NBB filings and Euronext notices for solvency and delisting signals.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameTitleSinceBackgroundEducationSource

Nicola d'Aniello

Founder; Chairman; CEO; Managing Director (administrateur délégué); investor relations

Founder 2003; CEO/Chair recorded from 18 Jul 2011

Nurse by training; founded the company; director of PNS since its listing

Nursing qualification (institution n/d)

MarketScreener; company website; La Province 18 Aug 2011

Directors' Remuneration

Governance attributeStatus

Chair / CEO separation

No — combined in the founder

Audit committee

n/d (not legally required for a non-regulated-market issuer of this size)

Corporate governance code compliance

Belgian Corporate Governance Code applies to regulated-market issuers; not applicable to a Marché Libre listing

Remuneration report

Not published

Proxy statement equivalent

AGM convening notices only (published on company website 2015-2022)

Major Shareholders

HolderStakeSource

Nicola d'Aniello (founder)

n/d (likely controlling; not disclosed)

—

Institutional holders (top 10)

None disclosed; no institutional ownership reported by data vendors

—

Total shares

612,500

Boursorama

Competitive Landscape

Key Competitors

CompetitorSegment overlapGeographyRevenueRelative positioningSource

Croix Jaune et Blanche (CJB)

Home nursing

Wallonia & Brussels

—

Large non-profit home-nursing federation; far greater scale and density

General industry knowledge; figures n/d

ASD – Aide & Soins à Domicile (Solidaris network)

Home nursing and home help

Wallonia & Brussels

—

Mutual-linked network with integrated referral access

General industry knowledge; figures n/d

Wit-Gele Kruis

Home nursing

Flanders

—

Dominant Flemish home-nursing provider; no direct geographic overlap

General industry knowledge; figures n/d

i-mens

Home nursing and care

Flanders

—

Large Flemish non-profit; no direct overlap

General industry knowledge; figures n/d

Independent self-employed nurses (thousands)

Home nursing

All Belgium

—

Fragmented, low-overhead competition in every commune

General industry knowledge

Eurocept Homecare

Specialised medical homecare ("hospital to home")

Benelux

€288.9M

Specialist with 250+ nurses and pharma/hospital partnerships; far larger

Gimv portfolio page

Hospital-at-home programmes of hospital networks (e.g., Hainaut hospital groups)

Hospitalisation at home

Hainaut

—

Vertically integrated with referral source

General industry knowledge

Medical equipment retailers / bandagisteries and pharmacies

Equipment sale and rental

Wallonia

—

Specialist retail with broader ranges

General industry knowledge

Residential and institutional care groups (e.g., LNA Santé, which operates in France, Belgium and Poland)

Institutional nursing (in-house staff substitutes for outsourcing)

Belgium (partly)

—

Large operators internalise nursing

Sustainability Reports profile of LNA Santé

Interim healthcare staffing agencies

Institutional nursing supply

Belgium

—

Compete for both institutional contracts and nurses

General industry knowledge

Peer Comparison FY2024

MetricUCare Services Belgique (FY2024)Eurocept Homecare

Revenue (EUR Mn)

1.75

288.9 (period n/d)

Revenue growth (%)

-34.2—

Net margin (%)

-38.9—

R&D intensity (%)

n/d (≈0)

—

Employees

32335

Recent Developments

The 18-month window (April 2025 – October 2026) contains only one verifiable development.

Within the 18-month window

DateEventSignificanceSource
24-25 Aug 2025FY2024 results: revenue €1.75M vs €2.66M; net loss €0.681M vs €0.014MRevenue -34%; loss equal to ≈2.8× market cap; signals severe operational stressS&P Capital IQ via MarketScreener
Oct 2026 (status at cut-off)No FY2025 results located; instrument still flagged inactive; no AGM notice published on company website since Dec 2022Disclosure gap; possible delayed accountsMarketScreener; company website

Prior disclosures (context, outside the window)

DateEventSignificanceSource
11 Aug 2023Last recorded price €0.40 (all-time low)Market value ≈€0.245MTradingView; FMP
2 Dec 2022Notice of AGM of 21 Dec 2022Last shareholder communication on websiteCompany website
15 Oct 2021Notice of AGM of 28 Oct 2021RoutineCompany website
7 Dec 2020Notice of AGM of 22 Dec 2020Routine (late AGM)Company website
12 Aug 2019Notice of AGM of 4 Oct 2019 at THG Group, LasneRoutineCompany website
2,019Mobile app rollout announcedDigital initiativeCompany website
Dec 2018Renamed UCare Services BelgiqueCorporate identityCompany website
14 Nov 2018Notice of AGM of 28 Nov 2018RoutineCompany website
9 Jul 2018Dividend coupon no. 10 (€0.10 for FY2016) paidLast dividendCompany website
26 Oct 2017Notice of AGM of 9 Nov 2017Approved FY2016 dividendCompany website
15 Dec 2016Dividend coupon no. 9 (€0.20 for FY2015), ex-date 19 Dec 2016Highest dividendCompany website
11 Jan 2016H1 2015 results: €2.381M (+7.3%); pre-tax operating result €0.258MProfitable phaseCompany press release

Aggregator claims not admitted to the register

Claimed dateClaimReason excluded
Mid-2025Partnership with Rede D'Or São Luiz for 60 hospitalsNo corroboration; Brazilian market; inconsistent with €1.75M Belgian business
Q3 2025BRL 150M funding round led by BNDES; Peru entryNo corroboration; would exceed company value by orders of magnitude
Oct 2025Launch of "UCare AI" nurse-matching serviceNo corroboration from company

Company Snapshot

$1.9M

Revenue

32

Employees

2003

Founded

Mons, Belgium

Headquarters

SWOT Analysis

Strengths

  • Long operating record: activity since 2003 and listed since 2006, giving two decades of local referral relationships (company website; La Province 2011).
  • Broad technical service range: palliative care, peritoneal dialysis, haemodialysis, stoma therapy and hospitalisation at home in addition to basic nursing (Investing.com; Euronext IPO summary).
  • Integrated offer: home care, institutional care and equipment sale/rental under one brand (MarketScreener three-pillar description; FinancialFilings four divisions).
  • Revenue resilience 2019-2023: revenue held in a €2.53-2.97M band for five years (MarketScreener).
  • Near-breakeven FY2023: net loss of only €13.6K on €2.66M revenue (S&P Capital IQ).
  • Past shareholder returns: dividends of €0.10 (FY2013), €0.20 (FY2015) and €0.10 (FY2016) (company dividend notices).

Weaknesses

  • Revenue collapse: FY2024 revenue down 34.2% to €1.75M (S&P Capital IQ).
  • Heavy loss: FY2024 net loss €0.681M, net margin -38.9% (S&P Capital IQ; calculated).
  • Long-term decline: revenue ≈59% below the c.2009 peak (calculated from L'Echo 2011 and S&P data).
  • Key-person dependence: founder is simultaneously Chairman, CEO, managing director and IR contact (MarketScreener; company website).
  • Minimal transparency: no published annual reports since at least FY2011 on Euronext; results surface only via S&P Capital IQ (MarketScreener news feed).
  • Illiquid, inactive listing: no trades since August 2023; instrument flagged inactive (TradingView; MarketScreener).

Opportunities

  • Ageing demographics increase demand for home nursing and palliative care (structural).
  • Hospital-at-home shift aligns with the company's stated aim of reducing hospital stays (FinancialFilings).
  • Franchise network leverage (UCare Services) could provide brand and process support (company website, 2014 integration).
  • Digital patient tools: the 2019 app could support scheduling efficiency if developed (company website).
  • Strategic exit: at an implied €0.245M equity value, the patient base and referral network could interest a larger provider (inference from market cap).
  • Equipment rental growth as a less labour-intensive revenue stream (L'Echo 2009 "third pillar").

Threats

  • Nurse shortage limiting capacity (FY2011 CEO commentary on recruitment dependency).
  • Wage indexation versus regulated tariffs compressing margins (L'Echo 25 Apr 2009).
  • Institutional contract losses: three residential contracts lost in Q4 2011 (FY2011 report); further losses would be material at current scale.
  • Competition from large non-profit networks and independent nurses with lower overhead.
  • Going-concern and solvency risk given FY2024 loss relative to scale (analytical inference; balance sheet n/d).
  • Delisting risk: inactive status and absence of recent disclosures (MarketScreener; FMP).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
24-25 Aug 2025FY2024 results: revenue €1.75M vs €2.66M; net loss €0.681M vs €0.014M S&P Capital IQ via MarketScreenerRevenue -34%; loss equal to ≈2.8× market cap; signals severe operational stress
Oct 2026 (status at cut-off)No FY2025 results located; instrument still flagged inactive; no AGM notice published on company website since Dec 2022 MarketScreener; company websiteDisclosure gap; possible delayed accounts
11 Aug 2023Last recorded price €0.40 (all-time low) TradingView; FMPMarket value ≈€0.245M
2 Dec 2022Notice of AGM of 21 Dec 2022 Company websiteLast shareholder communication on website
15 Oct 2021Notice of AGM of 28 Oct 2021 Company websiteRoutine
7 Dec 2020Notice of AGM of 22 Dec 2020 Company websiteRoutine (late AGM)
12 Aug 2019Notice of AGM of 4 Oct 2019 at THG Group, Lasne Company websiteRoutine
2019Mobile app rollout announced Company websiteDigital initiative
Dec 2018Renamed UCare Services Belgique Company websiteCorporate identity
14 Nov 2018Notice of AGM of 28 Nov 2018 Company websiteRoutine
9 Jul 2018Dividend coupon no. 10 (€0.10 for FY2016) paid Company websiteLast dividend
26 Oct 2017Notice of AGM of 9 Nov 2017 Company websiteApproved FY2016 dividend
15 Dec 2016Dividend coupon no. 9 (€0.20 for FY2015), ex-date 19 Dec 2016 Company websiteHighest dividend
11 Jan 2016H1 2015 results: €2.381M (+7.3%); pre-tax operating result €0.258M Company press releaseProfitable phase

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

5 charts
Revenue by Segment (FY2019–FY2024): Healthcare Facilities & Services revenue fell from EUR 2.5 Mn in FY2019 to EUR 1.8 Mn in FY2024.
Personalized Nursing Services Societe Anonyme — Revenue by Segment (FY2019–FY2024)
Series (EUR Mn)FY2019FY2020FY2021FY2022FY2023FY2024
Healthcare Facilities & Services revenue2.52.832.72.71.8

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. 1MarketScreener — Personalized Nursing Services quote page (PNSB, BE0003838555) — Inactive status, profile, executives, news list
  2. 2MarketScreener — Company page (sales by activity and geography FY2019-FY2023; address) — Revenue history; geography; governance
  3. 3MarketScreener / S&P Capital IQ — "Reports Earnings Results for the Full Year Ended December 31, 2024" (24-25 Aug 2025) — FY2024 and FY2023 revenue and net income
  4. 4Zonebourse — Personalized Nursing Services / Ucare Services Bel pages — French profile; press-release list
  5. 5Boursorama — Société UCARE SVC BE profile — Euronext Access segment; address; shares; market cap
  6. 6TradingView — EURONEXT:PNSB — Founding year, FIGI, all-time high/low
  7. 7Yahoo Finance — PNSB.BR — Last price
  8. 8FinancialModelingPrep — PNSB.BR — Inactive equity; shares outstanding
  9. 9Investing.com — Personalized Nursing Services company profile — Service list; incorporation year; employees
  10. 10FinancialFilings.com — Ucare Services Belgique — Four-division description
  11. 11UCare Services Belgique — investor pages ( pages 1-4) — Name change, franchise, identifiers, AGM notices, dividends, press archive (ucare-services.com)
  12. 12Euronext — PNS IPO showcase — IPO structure, warrants, broker, 2006 headcount
  13. 13Euronext Connect — PNS press release 30 Mar 2012 (FY2011 results) — FY2010-FY2011 figures; CML; Ciney
  14. 14Euronext Connect — PNS rapport annuel 2011 — Waterloo address; CEO commentary; contract terminations
  15. 15MarketScreener — Nicola d'Aniello insider profile — Founder role and start date
  16. 16a-leads — Personalized Nursing Services (PNS) s.a. — LinkedIn-derived headcount; Apr 2013 funding record
  17. 17Gimv — Eurocept Homecare portfolio page — Competitor scale
  18. 18Sustainability Reports — LNA Santé — Competitor footprint
  19. 19Euronext / Mondo Visione — Euronext Expert Market launch (Dec 2014) — Belgian market-segment context
  20. 20roic.ai — PNSB.BR — Uncorroborated claims flagged as erroneous

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.